Early Experience With Two-Fraction Spine Stereotactic Body Radiation Therapy in Treating Spinal Metastases
CONCLUSIONS: These findings suggest that 2-fraction spine SBRT is safe and effective, consistent with existing Level I evidence. Our local control rate exceeding 95% aligns with the literature, indicating the feasibility and achievability of implementing this approach in the United States over a short period of time.PMID:38372269 | DOI:10.1097/COC.0000000000001091 (Source: Clinical Lung Cancer)
Source: Clinical Lung Cancer - February 19, 2024 Category: Cancer & Oncology Authors: Ifeanyi O Ekpunobi Shearwood McClelland Source Type: research

Early Experience With Two-Fraction Spine Stereotactic Body Radiation Therapy in Treating Spinal Metastases
CONCLUSIONS: These findings suggest that 2-fraction spine SBRT is safe and effective, consistent with existing Level I evidence. Our local control rate exceeding 95% aligns with the literature, indicating the feasibility and achievability of implementing this approach in the United States over a short period of time.PMID:38372269 | DOI:10.1097/COC.0000000000001091 (Source: Clinical Breast Cancer)
Source: Clinical Breast Cancer - February 19, 2024 Category: Cancer & Oncology Authors: Ifeanyi O Ekpunobi Shearwood McClelland Source Type: research

Early Experience With Two-Fraction Spine Stereotactic Body Radiation Therapy in Treating Spinal Metastases
CONCLUSIONS: These findings suggest that 2-fraction spine SBRT is safe and effective, consistent with existing Level I evidence. Our local control rate exceeding 95% aligns with the literature, indicating the feasibility and achievability of implementing this approach in the United States over a short period of time.PMID:38372269 | DOI:10.1097/COC.0000000000001091 (Source: Clinical Genitourinary Cancer)
Source: Clinical Genitourinary Cancer - February 19, 2024 Category: Cancer & Oncology Authors: Ifeanyi O Ekpunobi Shearwood McClelland Source Type: research

Early Experience With Two-Fraction Spine Stereotactic Body Radiation Therapy in Treating Spinal Metastases
CONCLUSIONS: These findings suggest that 2-fraction spine SBRT is safe and effective, consistent with existing Level I evidence. Our local control rate exceeding 95% aligns with the literature, indicating the feasibility and achievability of implementing this approach in the United States over a short period of time.PMID:38372269 | DOI:10.1097/COC.0000000000001091 (Source: Cancer Control)
Source: Cancer Control - February 19, 2024 Category: Cancer & Oncology Authors: Ifeanyi O Ekpunobi Shearwood McClelland Source Type: research

Early Experience With Two-Fraction Spine Stereotactic Body Radiation Therapy in Treating Spinal Metastases
CONCLUSIONS: These findings suggest that 2-fraction spine SBRT is safe and effective, consistent with existing Level I evidence. Our local control rate exceeding 95% aligns with the literature, indicating the feasibility and achievability of implementing this approach in the United States over a short period of time.PMID:38372269 | DOI:10.1097/COC.0000000000001091 (Source: Clinical Prostate Cancer)
Source: Clinical Prostate Cancer - February 19, 2024 Category: Cancer & Oncology Authors: Ifeanyi O Ekpunobi Shearwood McClelland Source Type: research

Early Experience With Two-Fraction Spine Stereotactic Body Radiation Therapy in Treating Spinal Metastases
CONCLUSIONS: These findings suggest that 2-fraction spine SBRT is safe and effective, consistent with existing Level I evidence. Our local control rate exceeding 95% aligns with the literature, indicating the feasibility and achievability of implementing this approach in the United States over a short period of time.PMID:38372269 | DOI:10.1097/COC.0000000000001091 (Source: Clinical Lung Cancer)
Source: Clinical Lung Cancer - February 19, 2024 Category: Cancer & Oncology Authors: Ifeanyi O Ekpunobi Shearwood McClelland Source Type: research

Early Experience With Two-Fraction Spine Stereotactic Body Radiation Therapy in Treating Spinal Metastases
CONCLUSIONS: These findings suggest that 2-fraction spine SBRT is safe and effective, consistent with existing Level I evidence. Our local control rate exceeding 95% aligns with the literature, indicating the feasibility and achievability of implementing this approach in the United States over a short period of time.PMID:38372269 | DOI:10.1097/COC.0000000000001091 (Source: Clinical Breast Cancer)
Source: Clinical Breast Cancer - February 19, 2024 Category: Cancer & Oncology Authors: Ifeanyi O Ekpunobi Shearwood McClelland Source Type: research

Early Experience With Two-Fraction Spine Stereotactic Body Radiation Therapy in Treating Spinal Metastases
CONCLUSIONS: These findings suggest that 2-fraction spine SBRT is safe and effective, consistent with existing Level I evidence. Our local control rate exceeding 95% aligns with the literature, indicating the feasibility and achievability of implementing this approach in the United States over a short period of time.PMID:38372269 | DOI:10.1097/COC.0000000000001091 (Source: Clinical Genitourinary Cancer)
Source: Clinical Genitourinary Cancer - February 19, 2024 Category: Cancer & Oncology Authors: Ifeanyi O Ekpunobi Shearwood McClelland Source Type: research

Feasibility of Intraoperative Radiotherapy Tumor Bed Boost in Patients with Breast Cancer after Neoadjuvant Chemotherapy
CONCLUSION: Most patients successfully received IORT as a tumor bed boost after neoadjuvant chemotherapy. Thus, IORT may be a safe and feasible option for patients with advanced-stage breast cancer receiving neoadjuvant chemotherapy.PMID:38373832 | DOI:10.3349/ymj.2023.0229 (Source: Yonsei Medical Journal)
Source: Yonsei Medical Journal - February 19, 2024 Category: Universities & Medical Training Authors: Gowoon Yang Jun Won Kim Ik Jae Lee Joon Jeong Sung Gwe Ahn Soong June Bae Jee Hung Kim Yeona Cho Source Type: research

Feasibility of Intraoperative Radiotherapy Tumor Bed Boost in Patients with Breast Cancer after Neoadjuvant Chemotherapy
CONCLUSION: Most patients successfully received IORT as a tumor bed boost after neoadjuvant chemotherapy. Thus, IORT may be a safe and feasible option for patients with advanced-stage breast cancer receiving neoadjuvant chemotherapy.PMID:38373832 | DOI:10.3349/ymj.2023.0229 (Source: Yonsei Medical Journal)
Source: Yonsei Medical Journal - February 19, 2024 Category: Universities & Medical Training Authors: Gowoon Yang Jun Won Kim Ik Jae Lee Joon Jeong Sung Gwe Ahn Soong June Bae Jee Hung Kim Yeona Cho Source Type: research

Feasibility of Intraoperative Radiotherapy Tumor Bed Boost in Patients with Breast Cancer after Neoadjuvant Chemotherapy
CONCLUSION: Most patients successfully received IORT as a tumor bed boost after neoadjuvant chemotherapy. Thus, IORT may be a safe and feasible option for patients with advanced-stage breast cancer receiving neoadjuvant chemotherapy.PMID:38373832 | DOI:10.3349/ymj.2023.0229 (Source: Yonsei Medical Journal)
Source: Yonsei Medical Journal - February 19, 2024 Category: Universities & Medical Training Authors: Gowoon Yang Jun Won Kim Ik Jae Lee Joon Jeong Sung Gwe Ahn Soong June Bae Jee Hung Kim Yeona Cho Source Type: research

Feasibility of Intraoperative Radiotherapy Tumor Bed Boost in Patients with Breast Cancer after Neoadjuvant Chemotherapy
CONCLUSION: Most patients successfully received IORT as a tumor bed boost after neoadjuvant chemotherapy. Thus, IORT may be a safe and feasible option for patients with advanced-stage breast cancer receiving neoadjuvant chemotherapy.PMID:38373832 | DOI:10.3349/ymj.2023.0229 (Source: Yonsei Medical Journal)
Source: Yonsei Medical Journal - February 19, 2024 Category: Universities & Medical Training Authors: Gowoon Yang Jun Won Kim Ik Jae Lee Joon Jeong Sung Gwe Ahn Soong June Bae Jee Hung Kim Yeona Cho Source Type: research

Feasibility of Intraoperative Radiotherapy Tumor Bed Boost in Patients with Breast Cancer after Neoadjuvant Chemotherapy
CONCLUSION: Most patients successfully received IORT as a tumor bed boost after neoadjuvant chemotherapy. Thus, IORT may be a safe and feasible option for patients with advanced-stage breast cancer receiving neoadjuvant chemotherapy.PMID:38373832 | PMC:PMC10896667 | DOI:10.3349/ymj.2023.0229 (Source: Yonsei Medical Journal)
Source: Yonsei Medical Journal - February 19, 2024 Category: Universities & Medical Training Authors: Gowoon Yang Jun Won Kim Ik Jae Lee Joon Jeong Sung Gwe Ahn Soong June Bae Jee Hung Kim Yeona Cho Source Type: research

Feasibility of Intraoperative Radiotherapy Tumor Bed Boost in Patients with Breast Cancer after Neoadjuvant Chemotherapy
CONCLUSION: Most patients successfully received IORT as a tumor bed boost after neoadjuvant chemotherapy. Thus, IORT may be a safe and feasible option for patients with advanced-stage breast cancer receiving neoadjuvant chemotherapy.PMID:38373832 | PMC:PMC10896667 | DOI:10.3349/ymj.2023.0229 (Source: Yonsei Medical Journal)
Source: Yonsei Medical Journal - February 19, 2024 Category: Universities & Medical Training Authors: Gowoon Yang Jun Won Kim Ik Jae Lee Joon Jeong Sung Gwe Ahn Soong June Bae Jee Hung Kim Yeona Cho Source Type: research

Feasibility of Intraoperative Radiotherapy Tumor Bed Boost in Patients with Breast Cancer after Neoadjuvant Chemotherapy
CONCLUSION: Most patients successfully received IORT as a tumor bed boost after neoadjuvant chemotherapy. Thus, IORT may be a safe and feasible option for patients with advanced-stage breast cancer receiving neoadjuvant chemotherapy.PMID:38373832 | PMC:PMC10896667 | DOI:10.3349/ymj.2023.0229 (Source: Yonsei Medical Journal)
Source: Yonsei Medical Journal - February 19, 2024 Category: Universities & Medical Training Authors: Gowoon Yang Jun Won Kim Ik Jae Lee Joon Jeong Sung Gwe Ahn Soong June Bae Jee Hung Kim Yeona Cho Source Type: research